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Abstract
Coronary artery disease (CAD) mortality and morbidity is present in the European continent in a four-fold gradient across
populations, from the South (Spain and France) with the lowest CAD mortality, towards the North (Finland and UK). This
observed gradient has not been fully explained by classical or single genetic risk factors, resulting in some cases in the so
called Southern European or Mediterranean paradox. Here we approached population genetic risk estimates using genetic
risk scores (GRS) constructed with single nucleotide polymorphisms (SNP) from nitric oxide synthases (NOS) genes. These
SNPs appeared to be associated with myocardial infarction (MI) in 2165 cases and 2153 controls. The GRSs were computed
in 34 general European populations. Although the contribution of these GRS was lower than 1% between cases and
controls, the mean GRS per population was positively correlated with coronary incidence explaining 65–85% of the variation
among populations (67% in women and 86% in men). This large contribution to CAD incidence variation among
populations might be a result of colinearity with several other common genetic and environmental factors. These results are
not consistent with the cardiovascular Mediterranean paradox for genetics and support a CAD genetic architecture mainly
based on combinations of common genetic polymorphisms. Population genetic risk scores is a promising approach in
public health interventions to develop lifestyle programs and prevent intermediate risk factors in certain subpopulations
with specific genetic predisposition.
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Introduction
The development of coronary artery diseases (CAD) is the result
of complex interactions between numerous environmental factors
and genetic variants at many loci. Consequently, understanding
CAD needs a multidisciplinary research effort.
Initially, epidemiologic research was largely based on cohort
studies and clinical trials identifying and quantifying the relative
importance of risk factors. As the World Health Organization
(WHO) stated, the main identified risks for heart disease are
behavioral factors: unhealthy diet, physical inactivity, tobacco use
or harmful use of alcohol are present in about 80% of coronary
events [1]. Different consortia had contributed to the development
of estimation risk charts based on traditional risk factors (TRF),
such as the Framingham Risk Score [2], the Reynolds Risk Score
[3], the Prospective Cardiovascular Munster Heart Study
(PROCAM) [4] and the Systematic Coronary Risk Evaluation
(SCORE) system [5]. The prediction ability of these risk estimates
is moderate-good [6]. Nevertheless, it has been estimated that
nearly 15–20% of CAD patients are misclassified as ‘‘low risk’’ by
TRF-based charts [7].
Genetics provided a plausible explanation for disease outcome
in people without previous symptoms, and to the observed
symptomatic variability in people exposed to similar behavioral
risk factors. At the time that genetic disease architecture was
partially unveiled, the idea of improving cardiovascular risk
prediction was targeted. However, lack of replication, modest
genetic risks and the small proportion of heritability explained by
genome-wide association (GWA) studies have prevented the
improvement of genetic CAD prediction [8,9]. Even polygenetic
risk scores, proposed as a way of improving already existing
estimation risk charts, have not been completely satisfactory in
different epidemiologic samples [10–16]. All the approaches
mentioned above used individuals as the units of analysis.
From another perspective, in which general populations were
the units of analysis, ecological/epidemiological (from now on:
eco-epidemiologic) studies have assessed the disease population
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burden through the geographic distribution of CAD incidence and
risk parameters. In this field, an important contribution has been
made by the international WHO MONICA Project [17] which
surveyed 38 populations from 21 countries. As far as CAD
mortality was concerned, early cross-sectional studies reported an
existing four-fold gradient across populations in the European
continent, from the South (Spain and France) with the lowest
CAD mortality towards the North (Finland and UK) [18–20].
Several studies have attempted to correlate this observed CAD
incidence variation with the distribution of both traditional and
genetic risk factors. It was assessed that classical risk factors
contribute to 30–40% of CAD population incidence. Further-
more, an ecological fallacy was described when populations with
remarkable differences in coronary mortality had similar classical
risk factor levels, especially animal fat intake [21–23], leading to
the idea of a French, southern European or Mediterranean
paradox. However, a more recent study pointed towards wine
consumption as an alternative explanation for this phenomenon
[24]. The lack of strong correlations between CAD incidence and
traditional risk factors suggests that genetic variation could be
behind the interpopulation gradient of coronary mortality.
Some researchers have analyzed the geographic distribution of
genetic risk variants to predict variation in both TRF and CAD
mortality. So far, these studies have demonstrated that only the
APOE*E4 risk allele is clearly correlated with CAD incidence
among MONICA populations in the European continent. The
lack of correlation for the vast majority of tested genetic markers
led to extending the Mediterranean paradox to genetics [25,26].
This study proposes an alternative approach to estimating the
population genetic CAD burden using genetic risk scores (GRS).
GRS appear to be a more realistic tool because they summarize
the potential multiple risk genetic influences into a single
quantitative parameter and do not depend on single genetic
variants. As far as we know, no previous epidemiology studies have
considered GRS as ecological risk predictors of CAD incidence. In
order to describe geographic patterns of genetic risk variation, this
study maps the population mean GRS using the geostatistical
method known as kriging. Kriging is a geostatistic method for
interpolating the spatial distribution of a variable by means of
linear regression. Contour maps depicting interpolated spatial
distribution patterns have previously been used to represent
biologic anthropological data [27].
In order to explore these population approaches, we focused on
a key piece of the CAD jigsaw: the role of nitric oxide (NO) in
regulation of vascular tone homeostasis, tissue perfusion, and
platelet aggregation [28,29]. Three nitric oxide synthases (NOS)
are responsible for NO availability: endothelial NOS (eNOS or NOS3),
neuronal NOS (nNOS or NOS1) and inducible NOS (iNOS or NOS2A).
NOS3 and NOS1 are constitutively expressed mainly in vessel
endothelium and neuronal tissue, respectively [28]. Both are
acutely regulated through reversible calcium-calmodulin binding.
Conversely, NOS2A is activated through inflammatory signals in
critical situations, mainly in the vessel endothelium and macro-
phages. However, induction of high-output NOS2A may lead to
direct oxide cell toxicity or interfere with the beneficial activities of
constitutive NOS isoforms [28]. Besides NOS, sONE is an antisense
mRNA derived from a NOS3AS or ATG9B transcript unit on the
complementary DNA strand from which the NOS3 mRNA is
transcribed. ATG9B and NOS3 genes are oriented in a tail-to-tail
configuration, and the mRNAs encoding sONE and NOS3
overlap for 662 nucleotides. There is evidence supporting a role
for ATG9B in the post-transcriptional regulation of NOS3
expression [29]. According to the Human Genome Epidemiology
(HuGE) Navigator browser (www.hugenavigator.net), the NOS3
gene is the second most reported gene for CAD, with 134 related
papers, and the fourth most reported for myocardial infarction,
with 74 reports (February, 2014). Variation in NOS3 has also been
tested for hypertension and diabetes. However, large meta-analysis
on NOS3 gene polymorphisms reported inconsistent results for
CAD [30–33] and hypertension [34,35] showing an excess of
positive results associated with small sized studies and Asian
populations. NOS1 and NOS2A genes have been associated with
CAD, hypertension, inflammation and diabetes [36–39], but also
with a broader spectrum of diseases. All the above mentioned
association studies only considered a few polymorphisms per gene
region, and no one surveyed these chromosomal regions with a
dense genetic coverage.
In this context, the present work had three main objectives. The
first objective was to assess the prediction ability of GRS computed
from NOS risk variants detected by association analyses among
CAD patients and control samples. The second objective was to
estimate, for the first time, the population NOS CAD burden
computing GRS in general population samples, and to describe
geographic patterns of GRS across Europe and the Mediterranean
area. The third objective was to assess whether the population
GRS are able to predict ecological risk. With this aim, population
GRS were correlated with population distribution of CAD
incidence and other traditional risk factors reported by the
MONICA Project.
Materials and Methods
Ethics statement
The study has been specifically approved by the Ethical
Committee of the University of Barcelona (Institutional Review
Board: IRB00003099) and all the participants provided a written
informed consent.
Association and prediction analyses sample description
DNA samples of 324 myocardial infarction (MI) patients and
366 controls from the general Spanish population, obtained from
the Spanish National DNA Bank (NDB) (www.bancoadn.org),
were genotyped in this study. This sample will be referred to from
now on as NDB cardiovascular (NDBC) sample. Additionally,
genotype data from four European matched case-control samples
from the Myocardial Infarction Generation (MIGen) Consortium
[FINRISK (Finland), MDCS (Sweden), ATVB (Italy) and Regicor
(Spain)] were obtained through the database of Genotypes and
Phenotypes (dbGAP; www.ncbi.nlm.nih.gov/gap) [40]. In sum-
mary, a total of 2575 MI cases and 2617 controls were used in this
stage. Extensive details on the clinical characteristics of these
samples have been previously described (www.bancoadn.org/en/
introNCa.htm) [40]. Briefly, fatal and nonfatal MI were reported
or diagnosed by general practitioners based on autopsy reports,
electrocardiographic data, cardiac biomarkers, and additional
clinical information.
Eco-epidemiologic analyses sample description
A total of 34 populations (n = 1663 individuals) from Europe,
North Africa, and the Middle East were analyzed (see Figure S1).
Thirty populations (n = 1298) corresponded to healthy unrelated
individuals of both sexes that were genotyped in the present study
and whose four grandparents had been born in the same
geographical region. Additionally, genetic data from four other
European samples from the 1000 Genomes Project [41] were
included in the analyses.
Rejecting Genetic Mediterranean Paradox
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Polymorphisms and genotyping
The NDBC sample (324 cases and 366 controls) and 1298
individuals from the 30 general populations were genotyped for 78
single nucleotide polymorphisms (SNP) using a GoldenGate
Genotyping Assay (Illumina Inc., San Diego, CA). This SNP set
was selected as being representative of the common variation in
the three genomic regions of the NOS genes, with an average
coverage of 1 SNP every 5 kb with a minor allele frequency higher
than 0.05 (MAF.0.05) in the CEU population as reported in the
HapMap project (www.hapmap.org). Out of the 78 determined
SNPs, 13 were located in chromosome 7 spanning 41.4 kb in the
NOS3 and ATG9B genes region; 43 SNPs in chromosome 12 that
include the NOS1 gene along 177.4 kb, and 22 SNPs in
chromosome 17 covering 92.2 kb in the NOS2A gene region.
SNP details are shown in Table S1 in File S1.
Genotype data for the MIGen samples were generated in the
corresponding original project using the Affymetrix 6.0 GeneChip
[40].
Quality control and imputation
Genotyping rate, allele frequencies, and deviations from the
Hardy-Weinberg equilibrium (HWE) were calculated using
PLINK software [42]. SNPs with a genotyping rate lower than
0.75 or not polymorphic in any sample were removed from the
analysis. Individuals with a genotyping rate lower than 0.75 or not
genetically homogeneous compared with individuals of the same
population group were also removed for the analysis. Missing
genotypes were inferred using MACH 1.0 software [43] taking as
reference the rest of the genotypes ascertained in the same
population. Linkage disequilibrium was calculated and visualized
using Haploview software [44].
Datasets from the MIGen study already included 27 out of the
78 SNPs in the NOS regions. In order to have the same genetic
information, SNPs not directly genotyped in the MIGen samples
were imputed using two different imputation softwares, MACH
1.0 [43] and IMPUTE2 [45]. In both imputations the computa-
tional effort was controlled performing 200 algorithm iterations
when phasing and imputing data sets, and considering 300
haplotypes to use as templates when phasing observed genotypes.
This imputation effort is four times higher than the standard effort
recommended by software developers. Phased chromosomes from
the most similar 1000 Genomes Project samples were used as
reference panels: the FIN sample for the FINRISK case-controls,
the TSI sample for the ATVB and Regicor case-controls, and the
CEU sample for the MDCS case-controls.
As a control approach to validating the genotyping strategy of
this study (SNPs selected as representative of NOS regions common
variation), in our population sample from Central Italy (CIT) we
imputed all the variation described in TSI sample from the 1000
Genomes Project in the studied three chromosomal regions. And
then we checked the imputation quality indices regarding allele
frequency thresholds.
Association and prediction analysis
A two-step analysis of association and prediction was performed
with the PredictABEL R package [46]. These analyses were
performed in duplicate, in the MACH imputed data set and in
the IMPUTE2 imputed data set. In the first step, associations were
tested by logistic regression analysis in the three case-control
samples with the largest sample size: FINRISK from northern
Europe, and ATVB and Regicor from southern Europe. The
other two case-control samples (MDCS and NDBC) were kept as
cross-validating samples for the posterior prediction step. In the
association analyses, only SNPs with a LD measure (r2) lower than
0.8 between pairs and imputation quality indexes (r2 for MACH
1.0 and i for IMPUTE2) higher than 0.6 in all three used case-
control samples and the two imputation methods were included.
Estimates of beta coefficients for each SNP were obtained using
multivariate logistic regression analyses and adjusted for age,
gender and the remaining genetic variables. In order to get a single
robust estimate of the level of association for each genetic marker,
a meta-analysis of the three previous association analyses
(n = 4318) was conducted with the METAL software [47].
In the second step, NOS genetic risk scores for MI were
computed in all five case-control samples. Risk scores were
constructed using allele dosages of low P value (p,0.1) risk alleles
identified in both meta-analysis from MACH and IMPUTE2 data
sets. Thus, homozygotes for the reference allele were coded as 0
and homozygotes for the risk allele as 2. The risk SNPs were
pruned by LD (r2) lower than 0.2 in order to obtain a set of
unequivocally independent SNPs to calculate the risk scores. This
LD pruning was performed by Tagger [48], implemented in
Haploview [44], preferentially picking the SNPs with the lowest P
value. As an approach to checking for the epidemiological
relevance of the estimated risk scores, predictive models were
constructed based only on these NOS risk scores in all five case-
control samples. These models were performed to assess the
fraction of interindividual variance of the MI affection status
explained by NOS risk score through Nagelkerke’s R2. Moreover,
discrimination accuracy of the NOS risk score between patients
and healthy controls was estimated as the area under the receiver
operating characteristic (ROC) analysis curve (AUC) index.
Eco-epidemiologic analysis
NOS genetic risk scores for MI were computed in the general
population samples as previously described. NOS risk scores were
tested for normality in each population sample using the nortest R
package. Spatial distribution of mean risk score across populations
was mapped using the geostatistical method known as kriging from
the ArcGIS software (ESRI, Redlands, CA, USA). Since
anisotropy was not detected in the semivariogram, we used the
ordinary spherical interpolation kriging method [27]. The
covariation of the observed spatial distribution with geography
was assessed by Moran’s I and Geary’s C randomization tests for
spatial autocorrelation [49] using ade4 R package. Also, the spatial
structure of mean risk scores was assessed using correlograms,
which estimate autocorrelation coefficients for different spatial
relationships, with the PASSaGE software [50]. Population pair
relationships were classified in different classes representing
increasingly larger distances. Autocorrelation coefficients were
then calculated for each distance class and plotted against distance
[51]. Data related to coronary event rates and prevalence of
traditional risk factors in middle-aged individuals were compiled
from the MONICA Project [52] for the 11 European populations
genetically tested here. Among the genotyped populations in this
work, four of them (POL, NFR, SFR, and CAT) had a MONICA
counterpart and seven additional populations (ORK, GBR, CEU,
FIN, TSI, CIT and NBH) had a MONICA population within a
200-km radius or from the same country. The CEU sample was
considered counterpart of the MONICA German-Bremen popu-
lation according to Lao et al. [53]. Average annual coronary event
rates over 5 years and average levels of systolic blood pressure
(SBP), total cholesterol (TCH), body-mass index (BMI), and daily
smoking rate (SMK) by gender were obtained from Kuulasmaa
et al. [52].
Spearman’s correlation and univariate linear regression analyses
were performed to estimate the contribution of traditional risk
factors to population variation in coronary event rates using the
Rejecting Genetic Mediterranean Paradox
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stats R package. Since NOS genes are involved in blood pressure
homeostasis, NOS genetic parameters (population mean risk scores
and allele frequencies) were also correlated and regressed with
population variation in coronary event rate and systolic blood
pressure levels. Moreover, since geography could underlie the
distribution pattern of several environmental and genetic risk
factors, latitude and longitude were also tested for correlation and
regression with coronary event rates. Finally, multivariate regres-
sion analyses were performed with factors that were significant in
univariate analyses in order to estimate the contribution of genetic
risk factors beyond geography.
Results
Genotyping, quality control, and imputation
Genotyping rates and status for the 78 SNPs initially tested in
our samples are shown in Table S1 in File S1. Genotyping rates
ranged from 81.01 to 91.21%. Ten SNPs were not successfully
genotyped, and three SNPs were not polymorphic in the tested
populations. These 13 SNPs were removed from the study. As for
the data coming from the international project, genotyping status
and imputation quality indexes are presented in Table S1 in File
S1. Four SNPs had an imputation quality lower than 0.6 in at least
one case-control sample used in the association analyses. Hence,
61 SNPs were considered consistent for analytical epidemiologic
analyses.
After quality control, a total of 5096 samples for the
epidemiologic survey and 1298 for the population analysis were
included. The largest case-control sample was ATVB with a total
of 3352 individuals, and the smallest samples were FINRISK and
MDCS with 339 and 184 individuals (Table S2 in File S1). Among
the general populations, sample sizes ranged from 32 to 50
individuals except the populations from the 1000 Genomes project
(n = 85–98) as can be seen in Table S3 in File S1.
Minor allele frequencies (MAF) can be found in Table S4 and
Table S5 in File S1 for case-control samples imputed with MACH
and IMPUTE2 respectively, and in Table S6 in File S1 for
population samples. None of the SNP showed significant
departures from Hardy-Weinberg equilibrium expectations in
any case-control or population sample (data not shown).
Concerning linkage disequilibrium patterns, our data indicate
that the three NOS genes are not regions of high LD. For instance,
the LD pattern of the three NOS regions in the CEU sample can be
visualized in Figure S2 for NOS3 gene, Figure S3 for NOS1 gene
and Figure S4 for NOS2A gene. LD values were similar in the
different case-control samples used in this study. After applying the
LD pruning criteria for association analysis, 38 SNPs with low LD
(r2,0.8) were considered.
Assessing the validity of our genotyping strategy, 71% of the
common variants (MAF.0.1) present in the 1000 Genomes TSI
sample were imputed with high accuracy (MACH r2.0.75) in our
population samples from Central Italy, CIT (Table S7 in File S1).
Hence, this result indicates that our genotyping strategy (1SNP
each 5kb) efficiently captures more than 70% of the common
variation reported by the 1000 Genomes Project in the three
genomic regions.
Meta-analysis and interindividual prediction analysis
Five SNPs had low P value (p,0.1) in both MI meta-analysis
from MACH and IMPUTE2 data sets, four in the NOS3 and one
in the NOS1 gene regions (highlighted in Table S4 and Table S5 in
File S1). After LD pruning criteria (r2,0.2) to select completely
independent SNPs, four SNPs remained dropping one SNP from
NOS3. Genetic effects of these four SNPs with their standard error
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were similar for meta-analyses from MACH and IMPUTE2 data
sets (Table 1). Association parameters of all tested markers for both
multivariate logistic regression analyses and for both meta-analysis
are shown in Table S4 and Table S5 in File S1.
The assessment of interindividual predictive ability was almost
identical using MACH and IMPUTE2 imputations and showed
limited power in differentiating between cases and controls
(Table 2 for MACH data set, and Table S8 in File S1 for
IMPUTE2 data set). The distribution of NOS risk scores was
similar in cases and controls, showing almost overlapping
distributions. Besides, NOS risk score explained less than 1% of
interindividual variance in affection status according to the
Nagelkerke’s R2. NOS risk score was only a significant discrimi-
nating factor in the ATVB case-control sample. This was also
reflected by the discrimination accuracy assessed through AUC
index slightly higher than 0.5 in this sample.
Population distribution of NOS risk scores
The geographical distribution of mean NOS risk scores across
European and Mediterranean populations is represented in a
smoothed spherical contour map in Figure 1. Population values
are shown in Table S9 in File S1. The lowest score values
corresponded to southwestern European populations, specifically
to the islands of Corsica and Sardinia (,5.5 risk alleles), North-
East Spain (5.65) and South Italy (5.69). Variation in the map
fitted a global pattern of concentric distribution departing from a
center of low risk score values in the North-West of the
Mediterranean Basin and gradually increasing according to
geographical distances. This concentrical pattern significantly
covariated with geography as reflected by the spatial autocorre-
lation analysis (p = 0.024). At European continental level, the
pattern is consistent with a gradual increase towards North and
North-East, with highest values in Great Britain (6.04), Poland
(6.07) and Finland (6.14). A similar cline is also observed in the
northern shore of the Mediterranean, with increasing values from
Spain to Turkey (6.14) and Middle-Eastern populations, GJD
(6.02) and BJD (6.22). This clinal pattern in the European
continent and the Middle East was statistically assessed plotting
Moran’s I and Geary’s C autocorrelation coefficients by distance
between population pairs (Figure S5). Six distance classes of
population pairs with an average of 30 observations per class were
obtained. Autocorrelation coefficients for population pairs at short
distances denoted significant positive autocorrelations while for
population pairs at long distances Moran’s I and Geary’s C
coefficients detected negative autocorrelations. Concerning the
distribution between the northern and southern Mediterranean
shores, a gradual variation can be observed in the westernmost
part (Spain and Morocco), but the pattern is sharper in the central
part of the region (i.e. Tunisia and Italy).
Eco-epidemiology of NOS gene variation and
cardiovascular events
The eleven populations with both NOS genotype data and
MONICA information are shown in Table S10 in File S1. From
the MONICA parameters, only daily smoking rate appeared as
slightly correlated with coronary event rates in women (rho = 0.57;
p = 0.064) and explained 39% of the population variance of
coronary event rates (p = 0.022).
Mean NOS risk score values in the eleven populations
considered were positively correlated with coronary event rates
in men (rho = 0.82; p,0.01) (Figure 2A) and women (rho = 0.76;
p,0.01) (Figure 2B). In these figures, the ORK sample appeared
as substantially different from the others. In the regression analysis,
variation in mean risk scores explained 53% of interpopulation
variance in coronary event rates in men and 19% in women
(Table 3), and the ORK sample was confirmed as an outlier
sample (Bonferroni p,0.01 for both men and women). The ORK
sample and its MONICA counterpart were excluded from the
regression analyses. The outlier character of the Orkney Islands
sample was probably due to an island genetic drift phenomenon
when only a few markers are analyzed. Following this trend, any
MONICA parameter was correlated with coronary events in the
remaining ten MONICA samples, and the NOS risk score of the
ten continental samples significantly explained 86% of coronary
events in men and 67% in women (Table 3). Regarding SBP, 35%
for men and 27% for women of the population variance was
accounted for by the NOS risk score (Table 3). Individually,
frequency distributions of 11 SNPs were associated with popula-
tion coronary event rates or systolic blood pressure levels in men or
women as estimated by correlation and univariate regression
analyses (Table 3). Eight SNPs were correlated with coronary
events in both men and women, explaining a remarkable
proportion of the coronary rates variance: 34–67% in men and
36–52% in women. Out of these eight SNPs, 5 belonged to the
shortest (42kb) region examined comprising the NOS3 and ATG9B
genes. This region was initially tested by nine SNPs, indicating that
most of the tested genetic variation of this region had a similar
geographic distribution pattern to coronary event rates. Among
these SNPs correlating with CAD incidence, only the G risk allele
of the rs1799983 was included in the risk score. Moreover, the
same allele was the only one to be positively correlated with SBP in
both men and women, explaining similar proportions of
interpopulation variation, 40% in men (p,0.05) and 51% in
women (p,0.01) (Table 3).
Table 2. NOS genetic risk score (GRS) distribution for cases and controls and discrimination accuracy for MACH imputed dataset.
Case-control sample Mean risk score ± SD [min - max] Nagelkerke’s R2 AUC [95%CI]
cases controls
FINRISK (Findland) 6.1160.80 [4.00–7.97] 6.0560.85 [3.96–7.98] ,0.01 0.517 [0.455–0.578]
ATVB (Italy) 5.8860.68 [3.17–7.81] 5.8160.70 [3.60–7.83] ,0.01 0.527 [0.508–0.547]
Regicor (Spain) 5.7960.70 [3.88–7.46] 5.8860.71 [3.92–7.87] ,0.01 0.470 [0.425–0.515]
MDCS (Sweden) 5.8460.72 [4.01–7.67] 5.9660.64 [4.47–7.75] 0.01 0.448 [0.364–0.532]
NDBC (Spain) 5.7960.84 [4.00–8.00] 5.8560.88 [3.00–8.00] ,0.01 0.469 [0.426–0.513]
SD: Standard Deviation; Nagelkerke’s R2: explained interindividual variance of MI by NOS risk score predictive model; AUC: Area Under the receiver operating
characteristic (ROC) curve; CI: Confidence Interval.
doi:10.1371/journal.pone.0096504.t002
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Figure 1. Contour map of NOS risk score in the European and Mediterranean samples.
doi:10.1371/journal.pone.0096504.g001
Figure 2. Correlation plots between average NOS risk scores and coronary events in men (A) and women (B). Coronary events: rates per
100,000 people from the MONICA project.
doi:10.1371/journal.pone.0096504.g002
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Since north-to-south and east-to-west geographic patterns of
variation in genetic and environmental risk factors could underlie
the observed associations between polymorphisms in NOS regions
and coronary events, we then assessed the influence of geography
in the distribution of coronary events. Latitude was strongly
correlated in men (rho = 0.87; p,0.01) and women (rho = 0.75;
p,0.05) explaining a high proportion of population incidence
(66% in men and 38% in women).
Grouping the different parameters that were independently
correlated with coronary events rates, a multivariate analysis was
performed including the NOS risk score and the latitude in both
male and female models. The result showed latitude was no longer
significant, and the proportions of population coronary incidence
for both men and women accounted for by the multivariate
models were not higher compared with the NOS risk score
univariate models. For men, the multivariate model explained
85% of population coronary incidence (p,0.001; NOS risk score
p = 0.01, latitude p = 0.45). And for women, it explained 62% of
the population coronary events rate (p = 0.01; NOS risk score
p = 0.04, latitude = 0.82).
Discussion
This study analyzes the role of molecular variation from NOS
genes in cardiovascular patients and assesses the population
distribution of genetic risk scores as an ecological predictor of the
CAD burden across the European and Mediterranean landscape
for the first time. The NOS GRS included the 4 genetically
independent SNPs with lower P value associated with MI in a
meta-analysis of three European case-control studies. Since NOS
genes regulate the physiological availability of NO, this GRS
constitutes a polygenic approach to the potential contribution of
NO to CAD. The interindividual contribution of the GRS was
lower than 1%. However, from an ecological perspective, GRS
values across Europe were positively correlated with the incidence
of coronary events explaining 65–85% of interpopulation variation
of CAD incidence. These contrasting contributions and the
usefulness of GRSs as ecological predictors are discussed below.
Interindividual (intrapopulation) and interpopulation
contribution to CAD of NOS GRS
In the context of case-control studies, the NOS GRS was only a
significant MI risk factor in the sample with the largest size
(ATVB) but not in the other studies. Also, the AUC indicated that
the predictive value of the GRS was null or very limited (AUC of
0.527).
The weak effects of our GRS performed in terms of both
association and prediction are in complete accordance with
previous reports in the literature. The proportion of variance
explained by the relatively large number of loci associated with
CAD is lower than 1% [54]. In addition, the improvement in risk
prediction provided by genetic markers appeared to be null or
insufficient [55], even with the strongest and most replicated CAD
risk factor identified in the 9p21.3 locus [7,56]. When we move
from single genetic risk variants to a genomic profile, the
combined effect of dozens of risk variants generally explains only
a small proportion of disease variance [56] and shows a limited
predictive ability (AUC of 0.55–0.62) [6,55]. For instance, in the
MIGen Consortium, the effect of the nine top-associated loci
explained 2.8% of phenotype variance [40]. Even a more
comprehensive genetic risk score of 101 SNPs associated with
MI and other cardiovascular risk factors explained less than 5% of
interindividual variance [57]. In spite of the low genetic
contribution of genomic profiles, the genetic basis of CAD is
strong as reflected in family aggregation data (40% for women and
60% for men) [6,7,58]. The proportion of heritability that remains
unaccounted for (referred to as ‘‘missing heritability’’ elsewhere)
would be explained by common genetic variants (MAF .0.05)
having very small effects and rare variants with a larger
contribution to the complex phenotype [9,58–60].
The geographic distribution of GRS presented an interesting
variation pattern across European and Mediterranean popula-
tions. This distribution showed a concentric pattern from a center
of lower risk scores in North-Western Mediterranean, specially the
Islands of Corsica and Sardinia (Figure 1). The gradual increase
towards North (UK) and North-East Europe (Poland and Finland)
through the scarcely sampled area of North-Central Europe does
not seem unreasonable given the general trends across the
European continent and does not suggest any major problems
with spurious interpolation. This European south-to-north cline in
population GRS explained a large proportion of variance in
coronary incidence across 10 MONICA populations, 67% in
women and 86% in men (Figure 2). This large contribution
contrasts with the intrapopulation (i.e. interindividual) contribu-
tion of the GRS (,1%). Looking at single genetic markers to
understand this phenomenon, we have identified some genetic
variants, mainly in the NOS3/ATG9B region, with frequencies
correlating with CAD incidence. According to these correlations
all these variants would explain a similar proportion of variance in
CAD incidence (35–65%), but lower than GRS (Table 3). Out of
this group of correlating variants only rs1799983 was included in
the GRS. The other genetic variants correlating with CAD
incidence were not associated with CAD phenotype. In the
literature, empirical data on the ecological applications of GRSs
are lacking, but some studies have been done using single markers.
Previous studies on the correlation between risk allele frequencies
and CAD incidence across MONICA populations did not find
conclusive results [25,26]. One of these studies [26] extended the
Mediterranean paradox discussion into genetics due to the
observed negative correlations between some genetic risk factors
and CAD events. These authors concluded that the observed
north-to-south cline in the frequency of some genetic risk variants
was most probably the result of spatial distribution of the whole
genome variation present in the European continent, which has
been mainly shaped by the history of populations [61–63]. In this
context, the variance explained by the markers correlating with
CAD incidence in this study cannot be considered a specific effect
of each variant, but rather the combined effect of many risk
variants showing the same distribution. Thus, the apparent high
effect (46% in women and 61% in men) of the risk SNP rs1799983
is likely to be a colinearity effect with other risk genetic factors in
the regression analysis. In the same way, the estimated contribu-
tion of GRS (67% in women and 86% in men) would be the
consequence of the joint effect of risk variants from the common
frequency spectrum, with similar population patterns as the 4
SNPs included in the GRS. In other words, the contrasting
contributions from interindividual variance (,1%) to interpopu-
lation variance (65–85%) suggests that this GRS population
approach most probably suffers from colinearity with other genetic
as well as environmental risk factors. These results would support
that a high proportion of population CAD incidence is determined
by common genetic variant distributions because classical risk
factors contribute in 30–40% of CAD population incidence, and
because rare variants are basically population-specific and are not
distributed in population gradients [41,60].
The important genetic contribution to CAD incidence variation
suggests some considerations about the role of genetic factors on
the individual risk to CAD. High incidence of CAD in a
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population would be determined by high frequency of genetic risk
combinations and, hence, a high proportion of individuals
carrying these genetic risk combinations. In this ecological
approach, the GRS is capturing the contribution to CAD
incidence of the myriad of genetic risk variants with similar
geographic distribution. Thus, only the joint inclusion of this
myriad of genetic variants would explain a considerable propor-
tion of the genetic contribution to CAD outcome at the individual
level. In accordance with these results, previous studies have dealt
with the number and the effect sizes of the genetic variants
involved in the genetic architecture of CAD. These simulation
models predicted that the number of genetic variants needed to
explain the estimated heritability, under a purely additive model,
would range from few hundred low frequency variants with large
effect to several hundred or few thousand for common variants
with small effect [6,64,65].
In addition to the "Finland-to-Spain" axis, the variation in GRS
is also clinal between the West and East in the northern
Mediterranean shore. Although the correlation with CAD
incidence is not easy to demonstrate due to a sizeable lack of
epidemiological data in these populations, some partial data [66]
point in this direction. This constitutes an additional insight into
our working hypothesis on the correlation between CAD incidence
and GRS in Europe. So, the population distribution of both our
GRS and cardiovascular incidence are deeply influenced by
similar demographic processes that have modulated genetic
variation in current human groups. Available data in North
Africa [67] are too scarce to extend any conclusion to the southern
shore of the Mediterranean.
Usefulness of population GRS approach
In the European continent, environmental factors as well as
genetic variation seem to be structured in south-to-north clines
that can be correlated with observed CAD incidence as reflected
by latitude in our study. In previous data such as the original
MONICA project, modifiable risk factors explained only 30% of
coronary incidence variance [24]. And in this study, multivariate
analyses stressed the importance of GRS to explain the
distribution of CAD incidence, especially in men. These results
reflect that most variance in CAD incidence among populations is
accounted for by genetic background. A priori, this would contrast
with the fact that at the interindividual level (within a population)
environmental and behavioral factors are involved in 80% of all
cardiovascular events. However, they are two complementary
sides of the same phenomenon that explain different features of the
disease: individual outcome and population incidence. Whereas
within a population environmental factors explain a large
proportion of individual events, the total amount of coronary
events in populations under similar environmental pressures would
depend on their genetic predisposition. The potential incidence of
CAD in a population would be mainly determined by its genetic
risk background but it would be triggered by behavioral and life
style factors.
Our results highlight the usefulness of GRSs as population
estimates of the genetic burden of disease or as ecological
predictors. It has been stated that the assessment of disease risk
and its temporal trends is of critical importance to predict
incidences of CAD [68]. An ideal GRS would include all CAD risk
variants in the genome. Nevertheless, an exploratory strategy
could include the design of different GRSs for different
pathophysiological processes related to CAD, such as endothelial
dysfunction, accelerated atherosclerosis or thrombosis, each one
having its own genetic basis [68]. These GRSs could provide a
solid basis for developing lifestyle intervention programs to prevent
intermediate risk factors (e.g. obesity, high levels of blood pressure,
glucose and lipids) in population subgroups before environmental
factors trigger a potentially high genetic predisposition for the
disease.
Another particular advantage of GRS is that they can be
constructed from samples of a few hundreds of individuals per
population. High potential benefits, no interventional harms and
low cost make this approach very promising for future public
health studies.
Limitations
The analyses of this study have some limitations that can be
commented on. A first aspect refers to the genotyping strategy;
with the aim of capturing the maximum common genetic variation
in NOS genes we genotyped 1 SNP every 5 kb in our samples (65
SNPs in total). The accuracy of this strategy was assessed by
imputing all variants present in the TSI 1000 Genomes population
sample in our general population sample from Lazio, Italy
(genotyped with our set of 65 SNPs). From the result, we
concluded that this genotyping strategy was representative of .
70% of common genetic variation. Therefore, a remaining 30% of
common genetic variation of NOS genes is not well represented in
these analyses. Secondly, in MIGen case-control samples a
considerable proportion of genotypes (,60%) were imputed,
and, even though imputation quality controls were performed, this
fact could have affected the association and meta-analysis results.
In any case, this fact does not invalidate the GRS population
approach because the distribution of a robust (large number of
polymorphisms) GRS does not depend on the distribution of single
polymorphisms. Thirdly, the GRS in this study correspond only to
a small piece of the genetic basis of cardiovascular diseases jigsaw.
So, this initial study should be further developed beyond
polymorphisms in NOS genes. Finally, the size of the general
population samples was robust enough to check the frequency
distributions of polymorphisms. However, future studies should
include larger sample sizes if less common (,5%) polymorphisms
are to be included.
Conclusions
This study of cardiovascular NOS-GRS in European popula-
tions shows for the first time that GRSs are a powerful way of
analyzing the distribution of genetic risk and a promising tool for
ecological predictions of disease.
Although the contribution of GRS to CAD at the individual
level was lower than 1%, GRS explained a large proportion of
interpopulation differences in CAD incidence (65%–85%). This
large contribution to CAD incidence across populations might be
the result of colinearity with several other common genetic and
environmental factors. From the GRS perspective, the so-called
cardiovascular Mediterranean paradox would be no longer held
and CAD genetic architecture would be mainly based on common
genetic polymorphisms. The genetic risk score population
approach seems very promising in future public health interven-
tions to develop lifestyle programs and prevent intermediate risk
factors in population subgroups with especially high genetic
predisposition.
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Figure S1 Geographic population distribution of Euro-
pean and Mediterranean samples. See Table 3 in File S1 for
abbreviation codes.
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Figure S2 Plot of linkage disequilibrium (r2) between
tested genetic markers from NOS3/ATG9B region in
CEU sample.
(TIFF)
Figure S3 Plot of linkage disequilibrium (r2) between
tested genetic markers from NOS1 region in CEU
sample.
(TIFF)
Figure S4 Plot of linkage disequilibrium (r2) between
tested genetic markers from NOS2A region in CEU
sample.
(TIFF)
Figure S5 Correlograms of Moran’s I (A) and Geary’s C
(B) autocorrelation coefficients for different distance
classes of population pairs. Distances in kilometers. Full
circles mean significant coefficients.
(TIFF)
File S1 Tables S1-S10. Table S1. Genomic location of the
genetic variants, genotyping and imputation details. Chromosome
positions from Genome Reference Consortium human build 37
(GRCh37). GEN: Genotyped; IMP: Imputed. r2: MACH quality
metric. i: IMPUTE2 quality metric. Table S2. Original project,
sample size, gender ratio and age (mean, standard deviation and
range) of case-control samples. Table S3. Geographic origin,
population codification, sample size and geographic coordinates in
decimal degrees for the population samples. Table S4. Case-
control allele frequencies and association parameters of MAF
variants from MACH imputated data. LIQ: Low imputation
quality. LD: Excess linkage disequilibrium. SE: Standard Error. ‘:
P value,0.1; *: P value,0.05; **: P value,0.01. Table S5. Case-
control allele frequencies and association parameters of MAF
variants from IMPUTE2 imputated data. LIQ: Low imputation
quality. LD: Excess linkage disequilibrium. SE: Standard Error. ‘:
P value,0.1; *: P value,0.05; **: P value,0.01. Table S6. Minor
allele frequencies (MAF) for population samples. Table S7. Total
number of polymorphisms presented in TSI 1000 Genomes
Project sample (N polymorphisms) and rates of high accurately
imputed (MACH r2 .0.75) polymorphisms in CIT population
sample. Table S8. NOS genetic risk score (GRS) distribution for
cases and controls and discrimination accuracy for IMPUTE2
imputed dataset. SD: Standard Deviation; Nagelkerke’s R2:
explained interindividual variance of MI by NOS risk score
predictive model; AUC: Area Under the receiver operating
characteristic (ROC) curve; CI: Confidence Interval. Table S9.
Mean NOS risk score with standard deviation, minimum and
maximum for population samples. Table S10. Present study/
MONICA population pairs with coronary event rate and mean
levels of traditional risk factors separated by gender. CER: Mean
coronary event rates per 100,000 people over 5 years; SBP:
Systolic blood pressure (mm Hg); TCH: Total cholesterol (mmol/
L); BMI: Body-mass index (Kg/m2); SMK: Daily smoking rate
(%).
(XLSX)
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